| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 1 | 14 | 2023 | 567 | 3.150 |
Why?
|
| Autoimmunity | 9 | 2021 | 160 | 2.830 |
Why?
|
| Microbiota | 6 | 2023 | 381 | 1.800 |
Why?
|
| Intestines | 7 | 2019 | 411 | 1.770 |
Why?
|
| Autoimmune Diseases | 6 | 2015 | 241 | 1.720 |
Why?
|
| Immunity, Innate | 11 | 2019 | 409 | 1.640 |
Why?
|
| fas Receptor | 6 | 2014 | 75 | 1.280 |
Why?
|
| Intestinal Mucosa | 7 | 2019 | 797 | 1.270 |
Why?
|
| Immune Tolerance | 6 | 2020 | 337 | 1.230 |
Why?
|
| Host-Pathogen Interactions | 5 | 2015 | 231 | 1.140 |
Why?
|
| Histocompatibility Antigens Class II | 10 | 2021 | 158 | 1.120 |
Why?
|
| Mammary Tumor Virus, Mouse | 12 | 2017 | 63 | 1.120 |
Why?
|
| Adaptive Immunity | 6 | 2019 | 164 | 1.050 |
Why?
|
| Metagenome | 4 | 2013 | 102 | 1.040 |
Why?
|
| Fucose | 2 | 2015 | 13 | 1.040 |
Why?
|
| Mice | 63 | 2023 | 11352 | 1.030 |
Why?
|
| Toll-Like Receptors | 4 | 2015 | 92 | 1.030 |
Why?
|
| Retroviridae Infections | 11 | 2023 | 48 | 1.020 |
Why?
|
| Symbiosis | 3 | 2022 | 118 | 1.010 |
Why?
|
| Animals | 75 | 2023 | 26581 | 0.990 |
Why?
|
| Mice, Inbred NOD | 13 | 2023 | 187 | 0.940 |
Why?
|
| Bacteria | 8 | 2023 | 447 | 0.910 |
Why?
|
| Homeostasis | 4 | 2013 | 409 | 0.890 |
Why?
|
| Peyer's Patches | 4 | 2010 | 18 | 0.830 |
Why?
|
| Islets of Langerhans | 9 | 2020 | 544 | 0.820 |
Why?
|
| Dendritic Cells | 6 | 2019 | 425 | 0.760 |
Why?
|
| Mice, Transgenic | 15 | 2014 | 1540 | 0.730 |
Why?
|
| Sepsis | 2 | 2021 | 306 | 0.720 |
Why?
|
| T-Lymphocytes | 15 | 2014 | 1195 | 0.710 |
Why?
|
| Primates | 1 | 2021 | 151 | 0.700 |
Why?
|
| Insulin-Secreting Cells | 3 | 2012 | 397 | 0.620 |
Why?
|
| Gluconeogenesis | 1 | 2017 | 14 | 0.620 |
Why?
|
| Antigen Presentation | 7 | 2021 | 209 | 0.610 |
Why?
|
| Mice, Knockout | 20 | 2019 | 1924 | 0.580 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2019 | 683 | 0.580 |
Why?
|
| Lymphocytic Choriomeningitis | 2 | 2014 | 8 | 0.560 |
Why?
|
| Models, Immunological | 2 | 2013 | 80 | 0.540 |
Why?
|
| Mice, Inbred C57BL | 21 | 2020 | 3092 | 0.530 |
Why?
|
| B-Lymphocytes | 7 | 2007 | 724 | 0.520 |
Why?
|
| Lymphocytic choriomeningitis virus | 2 | 2014 | 13 | 0.510 |
Why?
|
| Antibodies, Neutralizing | 5 | 2020 | 112 | 0.490 |
Why?
|
| Bacterial Infections | 2 | 2013 | 182 | 0.490 |
Why?
|
| Gastrointestinal Tract | 2 | 2013 | 191 | 0.490 |
Why?
|
| T-Lymphocytes, Cytotoxic | 3 | 2012 | 315 | 0.490 |
Why?
|
| Lymphocyte Activation | 8 | 2014 | 728 | 0.480 |
Why?
|
| Disease | 1 | 2014 | 90 | 0.480 |
Why?
|
| Epithelium | 1 | 2014 | 319 | 0.470 |
Why?
|
| Intestine, Small | 2 | 2014 | 303 | 0.450 |
Why?
|
| CD8-Positive T-Lymphocytes | 6 | 2012 | 559 | 0.450 |
Why?
|
| Cytotoxicity, Immunologic | 4 | 2012 | 213 | 0.450 |
Why?
|
| Androgens | 1 | 2013 | 167 | 0.440 |
Why?
|
| Superantigens | 5 | 2004 | 24 | 0.440 |
Why?
|
| Receptors, Immunologic | 3 | 2009 | 135 | 0.440 |
Why?
|
| Macrophages | 3 | 2013 | 554 | 0.440 |
Why?
|
| Interferon-gamma | 5 | 2018 | 444 | 0.430 |
Why?
|
| Antigen-Presenting Cells | 5 | 2007 | 139 | 0.420 |
Why?
|
| Receptors, Complement | 1 | 2012 | 46 | 0.420 |
Why?
|
| Nobel Prize | 1 | 2011 | 10 | 0.420 |
Why?
|
| Early Diagnosis | 1 | 2012 | 131 | 0.410 |
Why?
|
| Retroviridae | 2 | 2022 | 79 | 0.400 |
Why?
|
| Environment | 1 | 2013 | 219 | 0.400 |
Why?
|
| HLA-D Antigens | 3 | 2021 | 20 | 0.400 |
Why?
|
| Immune System | 1 | 2012 | 93 | 0.400 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2007 | 190 | 0.400 |
Why?
|
| Antigens, Viral | 5 | 2011 | 143 | 0.380 |
Why?
|
| Antigens, Bacterial | 1 | 2010 | 134 | 0.360 |
Why?
|
| Gene Expression Regulation | 5 | 2014 | 1920 | 0.360 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 4 | 1998 | 19 | 0.340 |
Why?
|
| Immunity, Mucosal | 3 | 2012 | 69 | 0.340 |
Why?
|
| Signal Transduction | 6 | 2015 | 3241 | 0.340 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2010 | 203 | 0.330 |
Why?
|
| Epithelial Cells | 2 | 2010 | 669 | 0.330 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2019 | 425 | 0.320 |
Why?
|
| Peptides | 5 | 2021 | 639 | 0.310 |
Why?
|
| Lymphotoxin-alpha | 2 | 2004 | 44 | 0.300 |
Why?
|
| Membrane Glycoproteins | 4 | 2004 | 428 | 0.300 |
Why?
|
| Toll-Like Receptor 4 | 5 | 2016 | 88 | 0.300 |
Why?
|
| Mice, Inbred BALB C | 10 | 2020 | 1047 | 0.290 |
Why?
|
| Germ-Free Life | 4 | 2015 | 69 | 0.280 |
Why?
|
| Tumor Virus Infections | 7 | 2011 | 81 | 0.270 |
Why?
|
| Cells, Cultured | 8 | 2019 | 2818 | 0.270 |
Why?
|
| Immunity, Humoral | 2 | 2017 | 67 | 0.260 |
Why?
|
| Dendritic Cells, Follicular | 2 | 2004 | 20 | 0.260 |
Why?
|
| Insulin | 4 | 2010 | 1160 | 0.260 |
Why?
|
| Interleukins | 2 | 2016 | 134 | 0.260 |
Why?
|
| Antibodies, Viral | 4 | 2018 | 293 | 0.250 |
Why?
|
| Mice, SCID | 4 | 2012 | 252 | 0.250 |
Why?
|
| Adoptive Transfer | 5 | 2012 | 168 | 0.240 |
Why?
|
| Cell Movement | 3 | 2016 | 758 | 0.240 |
Why?
|
| Major Histocompatibility Complex | 5 | 2019 | 81 | 0.240 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2006 | 272 | 0.240 |
Why?
|
| T-Lymphocytes, Regulatory | 5 | 2010 | 295 | 0.230 |
Why?
|
| Mice, Inbred Strains | 6 | 2020 | 307 | 0.230 |
Why?
|
| Fas Ligand Protein | 5 | 2019 | 49 | 0.230 |
Why?
|
| Humans | 25 | 2023 | 86601 | 0.220 |
Why?
|
| Chemotaxis | 1 | 2003 | 72 | 0.220 |
Why?
|
| Proteolysis | 1 | 2023 | 100 | 0.220 |
Why?
|
| Myeloid Differentiation Factor 88 | 2 | 2015 | 47 | 0.210 |
Why?
|
| Female | 24 | 2020 | 44507 | 0.210 |
Why?
|
| Glutens | 1 | 2023 | 76 | 0.210 |
Why?
|
| Inflammation | 4 | 2019 | 920 | 0.210 |
Why?
|
| Mice, Inbred C3H | 8 | 2011 | 370 | 0.200 |
Why?
|
| Viral Envelope Proteins | 3 | 2015 | 94 | 0.190 |
Why?
|
| Antigens, CD | 3 | 2003 | 458 | 0.190 |
Why?
|
| Endosomes | 3 | 1997 | 75 | 0.190 |
Why?
|
| Cell Differentiation | 2 | 2005 | 1458 | 0.190 |
Why?
|
| Endothelium, Vascular | 1 | 2003 | 435 | 0.190 |
Why?
|
| Leukemia | 1 | 2022 | 320 | 0.190 |
Why?
|
| Male | 17 | 2020 | 40956 | 0.180 |
Why?
|
| Pancreas, Exocrine | 1 | 2020 | 18 | 0.180 |
Why?
|
| Antibodies | 2 | 2021 | 350 | 0.180 |
Why?
|
| Ligands | 3 | 2016 | 433 | 0.180 |
Why?
|
| Gene Deletion | 2 | 2014 | 329 | 0.180 |
Why?
|
| Microcirculation | 1 | 2020 | 106 | 0.180 |
Why?
|
| Interleukin-1beta | 1 | 2019 | 78 | 0.180 |
Why?
|
| Receptors, Antigen, T-Cell | 4 | 2021 | 372 | 0.180 |
Why?
|
| Diet | 1 | 2023 | 443 | 0.180 |
Why?
|
| Myeloid Cells | 1 | 2019 | 98 | 0.170 |
Why?
|
| Rauscher Virus | 2 | 2017 | 8 | 0.170 |
Why?
|
| Apoptosis | 3 | 2003 | 1683 | 0.170 |
Why?
|
| Immunoglobulin G | 3 | 2018 | 456 | 0.170 |
Why?
|
| Polymorphism, Genetic | 2 | 2019 | 819 | 0.160 |
Why?
|
| Gene Expression | 4 | 2019 | 1284 | 0.160 |
Why?
|
| Viruses | 1 | 2018 | 78 | 0.160 |
Why?
|
| Clone Cells | 5 | 2012 | 213 | 0.150 |
Why?
|
| Phylogeny | 2 | 2015 | 1137 | 0.150 |
Why?
|
| Cell Line | 5 | 2014 | 2468 | 0.150 |
Why?
|
| Glycosylation | 2 | 2014 | 129 | 0.140 |
Why?
|
| Molecular Sequence Data | 5 | 2008 | 3030 | 0.140 |
Why?
|
| Lymphoid Tissue | 3 | 2006 | 57 | 0.140 |
Why?
|
| Specific Pathogen-Free Organisms | 3 | 2014 | 74 | 0.140 |
Why?
|
| Interleukin-23 | 1 | 2016 | 54 | 0.140 |
Why?
|
| Immunization | 1 | 2016 | 158 | 0.140 |
Why?
|
| Species Specificity | 3 | 2014 | 678 | 0.140 |
Why?
|
| Spleen | 5 | 2023 | 430 | 0.140 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2015 | 23 | 0.140 |
Why?
|
| Cell Polarity | 1 | 2016 | 115 | 0.140 |
Why?
|
| Immune Evasion | 2 | 2015 | 33 | 0.130 |
Why?
|
| Keratinocytes | 1 | 2016 | 143 | 0.130 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2015 | 49 | 0.130 |
Why?
|
| Glycine | 1 | 2005 | 90 | 0.130 |
Why?
|
| Obesity | 2 | 2014 | 963 | 0.130 |
Why?
|
| Citrobacter rodentium | 1 | 2014 | 13 | 0.130 |
Why?
|
| Fucosyltransferases | 1 | 2014 | 8 | 0.130 |
Why?
|
| Cell Communication | 2 | 2012 | 194 | 0.130 |
Why?
|
| Protective Factors | 1 | 2014 | 22 | 0.130 |
Why?
|
| Anorexia | 1 | 2014 | 30 | 0.130 |
Why?
|
| Anti-Infective Agents | 1 | 2015 | 89 | 0.130 |
Why?
|
| Endocytosis | 2 | 1997 | 177 | 0.120 |
Why?
|
| Cyclophosphamide | 1 | 2005 | 299 | 0.120 |
Why?
|
| Vero Cells | 1 | 2014 | 100 | 0.120 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 79 | 0.120 |
Why?
|
| Adjuvants, Immunologic | 1 | 2005 | 167 | 0.120 |
Why?
|
| Fatty Acids | 1 | 2014 | 130 | 0.120 |
Why?
|
| Pancreas | 2 | 2007 | 239 | 0.120 |
Why?
|
| Virulence Factors | 1 | 2014 | 108 | 0.120 |
Why?
|
| Antibodies, Monoclonal | 5 | 1998 | 1376 | 0.120 |
Why?
|
| Communicable Diseases | 1 | 2014 | 63 | 0.120 |
Why?
|
| Castration | 1 | 2013 | 41 | 0.120 |
Why?
|
| Insulin Resistance | 2 | 2014 | 377 | 0.120 |
Why?
|
| Eating | 1 | 2014 | 166 | 0.120 |
Why?
|
| Skin | 1 | 2016 | 554 | 0.110 |
Why?
|
| Transgenes | 2 | 2007 | 180 | 0.110 |
Why?
|
| Sex Characteristics | 2 | 2013 | 319 | 0.110 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2014 | 204 | 0.110 |
Why?
|
| Monocytes | 1 | 2014 | 214 | 0.110 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2012 | 54 | 0.110 |
Why?
|
| Mice, Inbred CBA | 5 | 2004 | 52 | 0.110 |
Why?
|
| Cell Survival | 2 | 2014 | 969 | 0.110 |
Why?
|
| Caspase 1 | 2 | 2019 | 18 | 0.110 |
Why?
|
| Cell Compartmentation | 3 | 2004 | 69 | 0.100 |
Why?
|
| Immunomodulation | 1 | 2012 | 55 | 0.100 |
Why?
|
| Antigens | 2 | 2016 | 228 | 0.100 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2011 | 40 | 0.100 |
Why?
|
| Lymphocytes | 1 | 2013 | 464 | 0.100 |
Why?
|
| Inflammation Mediators | 1 | 2012 | 154 | 0.100 |
Why?
|
| Enteritis | 1 | 2010 | 21 | 0.100 |
Why?
|
| Probiotics | 1 | 2012 | 81 | 0.100 |
Why?
|
| Chronic Disease | 1 | 2014 | 970 | 0.100 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2010 | 33 | 0.090 |
Why?
|
| Muscle, Skeletal | 1 | 2014 | 449 | 0.090 |
Why?
|
| H-2 Antigens | 3 | 1987 | 58 | 0.090 |
Why?
|
| Ephrin-B2 | 1 | 2010 | 3 | 0.090 |
Why?
|
| History, 20th Century | 1 | 2011 | 312 | 0.090 |
Why?
|
| Pancreatitis | 1 | 2010 | 87 | 0.090 |
Why?
|
| Hybridomas | 2 | 1995 | 74 | 0.090 |
Why?
|
| Receptor, EphB4 | 1 | 2010 | 24 | 0.090 |
Why?
|
| Herpesvirus 2, Human | 1 | 2010 | 45 | 0.090 |
Why?
|
| Arteriovenous Malformations | 1 | 2010 | 41 | 0.090 |
Why?
|
| Receptor, Notch1 | 1 | 2010 | 85 | 0.090 |
Why?
|
| Molecular Targeted Therapy | 1 | 2012 | 266 | 0.090 |
Why?
|
| Mycoses | 1 | 2009 | 46 | 0.090 |
Why?
|
| RNA, Messenger | 3 | 2012 | 1981 | 0.090 |
Why?
|
| Amino Acids | 2 | 2009 | 252 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2012 | 339 | 0.090 |
Why?
|
| Hematopoiesis | 2 | 2016 | 163 | 0.090 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2010 | 176 | 0.080 |
Why?
|
| Vaccination | 1 | 2010 | 254 | 0.080 |
Why?
|
| Interleukin-2 | 1 | 2009 | 249 | 0.080 |
Why?
|
| Fatty Liver | 1 | 2009 | 124 | 0.080 |
Why?
|
| Adipocytes | 1 | 2009 | 155 | 0.080 |
Why?
|
| Peptide Fragments | 1 | 2010 | 460 | 0.080 |
Why?
|
| Herpes Simplex | 1 | 2010 | 202 | 0.080 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2005 | 1075 | 0.080 |
Why?
|
| Integrases | 1 | 2007 | 59 | 0.080 |
Why?
|
| CD11c Antigen | 1 | 2007 | 11 | 0.080 |
Why?
|
| Adipose Tissue | 1 | 2009 | 240 | 0.080 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2007 | 131 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 1 | 2007 | 305 | 0.070 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2006 | 88 | 0.070 |
Why?
|
| Chromosome Mapping | 2 | 2020 | 1074 | 0.070 |
Why?
|
| Leukemia Virus, Murine | 2 | 2023 | 18 | 0.070 |
Why?
|
| Interleukin-10 | 3 | 2015 | 149 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 2232 | 0.070 |
Why?
|
| Lipopolysaccharides | 3 | 2015 | 286 | 0.070 |
Why?
|
| Virus Replication | 3 | 2011 | 319 | 0.070 |
Why?
|
| Genes, MHC Class I | 2 | 2003 | 48 | 0.070 |
Why?
|
| Dermatitis | 1 | 2005 | 32 | 0.070 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2019 | 241 | 0.060 |
Why?
|
| Receptors, Cell Surface | 2 | 2003 | 286 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2005 | 2357 | 0.060 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2003 | 10 | 0.060 |
Why?
|
| Pertussis Toxin | 1 | 2003 | 31 | 0.060 |
Why?
|
| Endoglin | 1 | 2003 | 20 | 0.060 |
Why?
|
| Receptors, Chemokine | 1 | 2003 | 31 | 0.060 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2003 | 5 | 0.060 |
Why?
|
| Culture Techniques | 1 | 2003 | 91 | 0.060 |
Why?
|
| Neutrophil Activation | 1 | 2003 | 11 | 0.060 |
Why?
|
| Protein Binding | 2 | 2015 | 1456 | 0.060 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2003 | 56 | 0.060 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2003 | 73 | 0.060 |
Why?
|
| Endogenous Retroviruses | 1 | 2002 | 10 | 0.060 |
Why?
|
| Metabolomics | 1 | 2023 | 68 | 0.050 |
Why?
|
| Models, Biological | 1 | 2009 | 1749 | 0.050 |
Why?
|
| Crosses, Genetic | 4 | 2009 | 171 | 0.050 |
Why?
|
| Blotting, Western | 3 | 2014 | 782 | 0.050 |
Why?
|
| Lymphocyte Transfusion | 1 | 2001 | 41 | 0.050 |
Why?
|
| Cell Adhesion | 1 | 2003 | 420 | 0.050 |
Why?
|
| Injections, Intravenous | 1 | 2001 | 244 | 0.050 |
Why?
|
| Enterotoxins | 1 | 2001 | 19 | 0.050 |
Why?
|
| Animals, Newborn | 3 | 2011 | 510 | 0.050 |
Why?
|
| Mice, Congenic | 1 | 2020 | 12 | 0.050 |
Why?
|
| Base Sequence | 2 | 1995 | 2330 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2009 | 2356 | 0.050 |
Why?
|
| Carcinogenesis | 1 | 2022 | 195 | 0.050 |
Why?
|
| Lymphocyte Culture Test, Mixed | 4 | 1990 | 74 | 0.050 |
Why?
|
| Caspase 8 | 1 | 2019 | 34 | 0.050 |
Why?
|
| Defensins | 1 | 2019 | 5 | 0.050 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2001 | 124 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2019 | 43 | 0.050 |
Why?
|
| Membrane Proteins | 2 | 2006 | 1196 | 0.050 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1999 | 135 | 0.050 |
Why?
|
| Inflammasomes | 1 | 2019 | 23 | 0.040 |
Why?
|
| Capillaries | 1 | 2020 | 91 | 0.040 |
Why?
|
| Printing, Three-Dimensional | 1 | 2020 | 37 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2010 | 1753 | 0.040 |
Why?
|
| Time Factors | 1 | 2008 | 5209 | 0.040 |
Why?
|
| Immunoglobulin M | 1 | 1999 | 154 | 0.040 |
Why?
|
| Cell Count | 1 | 1999 | 195 | 0.040 |
Why?
|
| Genes, Immunoglobulin | 1 | 1999 | 111 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2019 | 155 | 0.040 |
Why?
|
| Lymph Nodes | 3 | 2016 | 530 | 0.040 |
Why?
|
| Immunocompromised Host | 1 | 2019 | 140 | 0.040 |
Why?
|
| Amino Acid Sequence | 2 | 2002 | 2062 | 0.040 |
Why?
|
| Dimerization | 1 | 1998 | 143 | 0.040 |
Why?
|
| Genes, MHC Class II | 2 | 1997 | 30 | 0.040 |
Why?
|
| Thymus Gland | 2 | 1997 | 195 | 0.040 |
Why?
|
| Drug Resistance | 2 | 1989 | 256 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 2 | 1995 | 100 | 0.040 |
Why?
|
| Staphylococcus aureus | 1 | 2001 | 263 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 1997 | 279 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2020 | 1373 | 0.040 |
Why?
|
| Biological Transport | 2 | 1995 | 396 | 0.040 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2019 | 186 | 0.040 |
Why?
|
| Proteins | 1 | 2003 | 777 | 0.040 |
Why?
|
| Hepatitis B | 1 | 2017 | 74 | 0.040 |
Why?
|
| Rats | 3 | 1997 | 3990 | 0.040 |
Why?
|
| Transfection | 2 | 1997 | 896 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2017 | 498 | 0.040 |
Why?
|
| Epidermis | 1 | 2016 | 100 | 0.030 |
Why?
|
| Clonal Deletion | 1 | 1995 | 23 | 0.030 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1995 | 95 | 0.030 |
Why?
|
| Protein Conformation | 1 | 1998 | 881 | 0.030 |
Why?
|
| Lectins, C-Type | 1 | 1995 | 85 | 0.030 |
Why?
|
| CD40 Antigens | 1 | 1995 | 43 | 0.030 |
Why?
|
| CD40 Ligand | 1 | 1995 | 69 | 0.030 |
Why?
|
| Injections, Intraperitoneal | 1 | 2005 | 102 | 0.030 |
Why?
|
| Cell Membrane | 1 | 1998 | 666 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 1997 | 679 | 0.030 |
Why?
|
| Hepatitis C | 1 | 2017 | 208 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 1998 | 673 | 0.030 |
Why?
|
| Allergy and Immunology | 1 | 2014 | 12 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2005 | 303 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2005 | 391 | 0.030 |
Why?
|
| Freund's Adjuvant | 1 | 2014 | 26 | 0.030 |
Why?
|
| Antigens, Viral, Tumor | 1 | 1994 | 15 | 0.030 |
Why?
|
| Mice, Obese | 1 | 2014 | 44 | 0.030 |
Why?
|
| Lymphocyte Depletion | 2 | 2010 | 97 | 0.030 |
Why?
|
| Computational Biology | 1 | 2017 | 528 | 0.030 |
Why?
|
| Ovalbumin | 1 | 2014 | 109 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1994 | 316 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 1997 | 937 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2005 | 458 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 1995 | 927 | 0.030 |
Why?
|
| DNA Primers | 1 | 1994 | 543 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 2270 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2005 | 1041 | 0.030 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2019 | 455 | 0.030 |
Why?
|
| Radiotherapy | 1 | 2005 | 328 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 376 | 0.030 |
Why?
|
| Phenotype | 3 | 2010 | 2377 | 0.030 |
Why?
|
| Epitopes | 2 | 1990 | 255 | 0.030 |
Why?
|
| Fibroblasts | 1 | 1994 | 729 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2005 | 1685 | 0.020 |
Why?
|
| Aging | 1 | 1995 | 691 | 0.020 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2011 | 105 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2010 | 147 | 0.020 |
Why?
|
| Pregnancy | 2 | 2011 | 2893 | 0.020 |
Why?
|
| CD3 Complex | 1 | 2010 | 135 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2016 | 1578 | 0.020 |
Why?
|
| Autophagy-Related Protein 5 | 1 | 2010 | 11 | 0.020 |
Why?
|
| Radiation Chimera | 1 | 2010 | 23 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 977 | 0.020 |
Why?
|
| 3T3-L1 Cells | 1 | 2009 | 32 | 0.020 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2009 | 26 | 0.020 |
Why?
|
| Autoantigens | 1 | 2010 | 127 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2010 | 207 | 0.020 |
Why?
|
| Gene Knock-In Techniques | 1 | 2009 | 28 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2010 | 369 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2009 | 38 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2009 | 78 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2009 | 135 | 0.020 |
Why?
|
| Horseradish Peroxidase | 1 | 1988 | 35 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 1988 | 129 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2010 | 557 | 0.020 |
Why?
|
| alpha-Fetoproteins | 1 | 1988 | 45 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 1988 | 129 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 1621 | 0.020 |
Why?
|
| Kinetics | 2 | 2004 | 1513 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 547 | 0.020 |
Why?
|
| Mutation | 2 | 2017 | 3967 | 0.020 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2007 | 13 | 0.020 |
Why?
|
| Cross Reactions | 2 | 2003 | 106 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 2767 | 0.020 |
Why?
|
| Tumor Necrosis Factor Ligand Superfamily Member 14 | 1 | 2006 | 14 | 0.020 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 2006 | 5 | 0.020 |
Why?
|
| Lymphotoxin beta Receptor | 1 | 2006 | 29 | 0.020 |
Why?
|
| Prediabetic State | 1 | 2006 | 39 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 746 | 0.020 |
Why?
|
| Adult | 2 | 2016 | 25640 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2006 | 148 | 0.020 |
Why?
|
| Alleles | 1 | 2009 | 1127 | 0.020 |
Why?
|
| Immunoglobulin Allotypes | 1 | 1985 | 5 | 0.020 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 1985 | 96 | 0.020 |
Why?
|
| Complement System Proteins | 1 | 1984 | 81 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2004 | 148 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2007 | 429 | 0.020 |
Why?
|
| Interleukin-18 | 1 | 2004 | 26 | 0.020 |
Why?
|
| Interleukin-1 | 1 | 2004 | 71 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2007 | 444 | 0.010 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2003 | 44 | 0.010 |
Why?
|
| Postpartum Period | 1 | 2004 | 135 | 0.010 |
Why?
|
| Mitochondria | 1 | 2007 | 535 | 0.010 |
Why?
|
| Genes, env | 1 | 2002 | 8 | 0.010 |
Why?
|
| Neutralization Tests | 1 | 2003 | 77 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2007 | 536 | 0.010 |
Why?
|
| Milk | 1 | 2003 | 53 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2002 | 94 | 0.010 |
Why?
|
| Lymphotoxin-beta | 1 | 2002 | 7 | 0.010 |
Why?
|
| Genes, RAG-1 | 1 | 2002 | 13 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2007 | 873 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 1984 | 269 | 0.010 |
Why?
|
| Isoantigens | 1 | 2002 | 66 | 0.010 |
Why?
|
| Mammary Glands, Animal | 1 | 2003 | 78 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2002 | 137 | 0.010 |
Why?
|
| Sheep | 1 | 2002 | 239 | 0.010 |
Why?
|
| Chemokines | 1 | 2002 | 73 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2002 | 416 | 0.010 |
Why?
|
| Erythrocytes | 1 | 2002 | 255 | 0.010 |
Why?
|
| DNA | 2 | 1989 | 1294 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 1014 | 0.010 |
Why?
|
| Macromolecular Substances | 2 | 1995 | 177 | 0.010 |
Why?
|
| Incidence | 1 | 2004 | 1576 | 0.010 |
Why?
|
| Selection, Genetic | 1 | 2003 | 502 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 1997 | 34 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1997 | 93 | 0.010 |
Why?
|
| Aged | 1 | 2014 | 18402 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2003 | 1351 | 0.010 |
Why?
|
| Emetine | 1 | 1995 | 2 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 1997 | 736 | 0.010 |
Why?
|
| HLA-DR Antigens | 1 | 1995 | 61 | 0.010 |
Why?
|
| Middle Aged | 1 | 2014 | 25017 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1995 | 989 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1992 | 135 | 0.010 |
Why?
|
| Reserpine | 1 | 1989 | 5 | 0.010 |
Why?
|
| Vincristine | 1 | 1989 | 111 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1989 | 256 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 1989 | 267 | 0.000 |
Why?
|
| Lymphoma | 1 | 1989 | 262 | 0.000 |
Why?
|
| Immunity, Cellular | 1 | 1987 | 177 | 0.000 |
Why?
|
| RNA | 1 | 1989 | 560 | 0.000 |
Why?
|
| Immunoglobulin Constant Regions | 1 | 1985 | 21 | 0.000 |
Why?
|
| Mice, Inbred A | 1 | 1982 | 23 | 0.000 |
Why?
|